StockGlow

RaySearch Laboratories AB (publ) (RAY-B.ST)

Makes software that helps cancer doctors plan and deliver radiation treatment.

177.40+0.01%Healthcare
Compare RAY-B.ST with
StockGlow Score
54
Neutral
BearishBullish
1 year ago-47.0%

The outlook

RAY-B.ST trades at 177.4 with analyst consensus rating Strong Buy, though coverage is thin at two analysts. The stock sits well below both its 50- and 200-day averages and near the lower end of its 52-week range, while the average analyst price target sits roughly 86% above the current price.

What’s behind the score

Analyst consensusStrong Buy — 1.0 avg of 2 analysts
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +86% vs current price

Analyst price target

~12-month · 2 analysts
330.00average target+86.0% vs now
Now 177.40
Low 290.00High 370.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$6.01B
52-wk high
365.50
52-wk low
153.10
50-day avg
210.41
200-day avg
207.83
Trailing P/E
27.1

Similar stocks

EKTA-B.STElekta AB (publ)$47.90-2.00%CEVI.STCellaVision AB (publ)$152.80+5.82%VITR.STVitrolife AB (publ)$86.85+0.40%CAMX.STCamurus AB (publ)$625.00+0.24%XVIVO.STXvivo Perfusion AB (publ)$253.20+0.80%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy